# BOLT (Bolt Biotherapeutics, Inc.) - SEC EDGAR Financial Statements

> Bolt Biotherapeutics, Inc. reported $2.53M in revenue and a net loss of $26.18M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -1098.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/BOLT
- Markdown: https://convexityos.com/fundamentals/BOLT.md
- SEC CIK: 0001641281
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001641281&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $2.53M | -100.0% YoY |
| Operating Income | TTM | -$27.79M | -1098.0% margin |
| Net Income | TTM | -$26.18M | -1034.4% net margin |
| Diluted EPS | TTM | -$13.32 | Split-adjusted |
| Free Cash Flow | TTM | -$39.92M | -1577.3% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $14.80M | Total debt: $20.89M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $7.70M | $7.69M | $7.88M | $5.73M | $1.26M | $231K |
| Research & Development | $28.53M | $57.47M | $61.54M | $73.12M | $75.66M | $40.36M |
| Total Operating Expenses | $43.81M | $80.74M | $84.07M | $96.05M | $94.05M | $49.41M |
| **Operating Income** | -$36.11M | -$73.05M | -$76.20M | -$90.32M | -$92.79M | -$49.18M |
| **EBITDA** | -$34.82M | -$71.27M | -$74.34M | -$88.66M | -$91.59M | -$48.57M |
| Income Before Tax | -$33.38M | -$63.12M | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$33.38M | -$63.12M | -$69.20M | -$88.10M | -$98.59M | -$60.73M |
| Basic EPS | -$17.40 | -$33.06 | -$1.83 | -$2.36 | -$2.97 | -$28.89 |
| **Diluted EPS** | -$17.40 | -$33.06 | -$1.83 | -$2.36 | -$2.97 | -$28.89 |
| Basic Shares Outstanding | 1.9M | 1.9M | 37.8M | 37.4M | 33.2M | 2.0M |
| Diluted Shares Outstanding | 1.9M | 1.9M | 37.8M | 37.4M | 33.2M | 2.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $5.0K | $26K | $2.50M | $2.17M | $1.80M | $1.22M | $0 |
| Research & Development | $2.21M | $4.72M | $5.25M | $4.99M | $6.54M | $7.50M | $9.51M | $11.72M |
| Total Operating Expenses | $4.73M | $7.95M | $8.05M | $9.59M | $9.87M | $11.01M | $13.34M | $16.92M |
| **Operating Income** | -$4.73M | -$7.95M | -$8.03M | -$7.08M | -$7.70M | -$9.21M | -$12.12M | -$16.92M |
| **EBITDA** | -$4.66M | -$7.78M | -$7.82M | -$6.83M | -$7.41M | -$8.86M | -$11.72M | -$16.49M |
| **Net Income** | -$4.42M | -$7.46M | -$7.67M | -$6.63M | -$7.14M | -$8.56M | -$11.04M | -$15.94M |
| Basic EPS | -$2.25 | -$3.88 | -$3.99 | -- | -$3.72 | -$4.46 | -$5.76 | -- |
| **Diluted EPS** | -$2.25 | -$3.88 | -$3.99 | -- | -$3.72 | -$4.46 | -$5.76 | -- |
| Basic Shares Outstanding | 2.0M | 1.9M | 1.9M | -- | 1.9M | 1.9M | 1.9M | -- |
| Diluted Shares Outstanding | 2.0M | 1.9M | 1.9M | -- | 1.9M | 1.9M | 1.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.70M | $7.21M | $10.81M | $9.24M | $27.38M | $5.54M |
| Short-Term Investments | $15.80M | $40.12M | $91.38M | $159.6M | $158.8M | $17.30M |
| **Cash & Short-Term Investments** | $31.80M | $70.20M | $128.6M | $192.8M | $186.2M | $22.84M |
| **Total Current Assets** | $30.26M | $50.81M | $105.7M | $172.7M | $189.2M | $25.36M |
| Property, Plant & Equipment, Net | $1.25M | $3.14M | $4.96M | $6.45M | $6.16M | $4.08M |
| Long-Term Investments | $4.34M | $22.88M | $26.41M | $23.94M | $85.35M | -- |
| Other Non-Current Assets | $138K | $62K | $1.82M | $1.03M | $1.04M | $909K |
| **Total Non-Current Assets** | $26.49M | $48.82M | $54.08M | $55.06M | $118.6M | $21.18M |
| **Total Assets** | $56.75M | $99.63M | $159.8M | $227.8M | $307.7M | $46.54M |
| Accounts Payable | $1.44M | $1.51M | $2.99M | $3.59M | $3.57M | $1.60M |
| Deferred Revenue (Current) | $449K | $3.02M | $2.20M | $1.40M | $2.87M | $1.50M |
| **Total Current Liabilities** | $8.44M | $15.86M | $20.46M | $23.12M | $21.33M | $11.26M |
| Deferred Revenue (Non-Current) | $1.54M | $3.62M | $9.11M | $12.92M | $14.21M | -- |
| Other Non-Current Liabilities | $132K | $0 | $43K | $42K | $210K | $329K |
| **Total Non-Current Liabilities** | $21.81M | $26.58M | $26.59M | $33.18M | $36.27M | $34.93M |
| **Total Liabilities** | $30.24M | $42.43M | $47.04M | $56.30M | $57.60M | $46.19M |
| **Total Debt (incl. Leases)** | $22.96M | $25.21M | $20.22M | $22.61M | $24.36M | $10.88M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | -- |
| Retained Earnings | -$460.8M | -$427.4M | -$364.3M | -$295.1M | -$207.0M | -$108.4M |
| Accumulated Other Comp. Income | -$21K | $97K | $37K | -$919K | -$321K | -- |
| **Total Stockholders' Equity** | $26.50M | $57.20M | $112.7M | $171.5M | $250.1M | -$104.9M |
| Total Equity | $26.50M | $57.20M | $112.7M | $171.5M | $250.1M | -$104.9M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $13.78M | $12.86M | $11.61M | $11.70M | $17.75M | $9.60M | $8.39M | $7.21M |
| Short-Term Investments | $1.02M | $4.74M | $11.28M | $15.80M | $14.16M | $25.17M | $30.45M | $40.12M |
| **Cash & Short-Term Investments** | $15.00M | $18.10M | $23.90M | $31.80M | $38.80M | $48.50M | $58.00M | $70.20M |
| **Total Current Assets** | $17.08M | $20.56M | $25.75M | $30.26M | $35.61M | $38.34M | $42.51M | $50.81M |
| Property, Plant & Equipment, Net | $341K | $408K | $1.04M | $1.25M | $1.50M | $1.72M | $2.06M | $3.14M |
| Long-Term Investments | $247K | $509K | $1.02M | $4.34M | $6.91M | $13.72M | $19.11M | $22.88M |
| Other Non-Current Assets | $18K | $87K | $112K | $138K | $179K | $222K | $51K | $62K |
| **Total Non-Current Assets** | $18.51M | $19.62M | $22.27M | $26.49M | $29.45M | $37.16M | $43.35M | $48.82M |
| **Total Assets** | $35.59M | $40.18M | $48.03M | $56.75M | $65.05M | $75.50M | $85.86M | $99.63M |
| Accounts Payable | $633K | $868K | $1.74M | $1.44M | $1.52M | $1.85M | $1.53M | $1.51M |
| Deferred Revenue (Current) | $1.07M | $819K | $630K | $449K | $1.91M | $2.51M | $3.08M | $3.02M |
| **Total Current Liabilities** | $8.31M | $7.87M | $7.77M | $8.44M | $9.97M | $12.31M | $13.56M | $15.86M |
| Deferred Revenue (Non-Current) | $924K | $1.17M | $1.35M | $1.54M | $1.96M | $2.59M | $3.05M | $3.62M |
| Other Non-Current Liabilities | $132K | $132K | $158K | $132K | $133K | $133K | $132K | $0 |
| **Total Non-Current Liabilities** | $18.71M | $19.84M | $20.86M | $21.81M | $22.99M | $24.35M | $25.49M | $26.58M |
| **Total Liabilities** | $27.03M | $27.70M | $28.63M | $30.24M | $32.95M | $36.66M | $39.05M | $42.43M |
| **Total Debt (incl. Leases)** | $20.89M | $21.62M | $22.31M | $22.96M | $23.59M | $24.18M | $24.71M | $25.21M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$480.3M | -$475.9M | -$468.4M | -$460.8M | -$454.1M | -$447.0M | -$438.4M | -$427.4M |
| Accumulated Other Comp. Income | -$43K | -$44K | -$11K | -$21K | -$10K | -$6.0K | $40K | $97K |
| **Total Stockholders' Equity** | $8.56M | $12.48M | $19.40M | $26.50M | $32.10M | $38.84M | $46.81M | $57.20M |
| Total Equity | $8.56M | $12.48M | $19.40M | $26.50M | $32.10M | $38.84M | $46.81M | $57.20M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$33.38M | -$63.12M | -$69.20M | -$88.10M | -$98.59M | -$60.73M |
| Depreciation & Amortization | $1.29M | $1.78M | $1.85M | $1.67M | $1.19M | $611K |
| Stock-Based Compensation | $2.78M | $7.41M | $9.22M | $9.58M | $8.50M | $1.42M |
| **Operating Cash Flow** | -$39.85M | -$61.29M | -$69.53M | -$76.50M | -$57.07M | -$47.31M |
| Capital Expenditure | -$72K | -$41K | -$206K | -$1.95M | -$2.34M | -$3.26M |
| **Free Cash Flow** | -$39.92M | -$61.33M | -$69.73M | -$78.46M | -$59.40M | -$50.57M |
| Purchases of Investments | -$29.02M | -$88.86M | -$165.0M | -$180.7M | -$313.4M | -$33.23M |
| **Investing Cash Flow** | $44.30M | $57.58M | $71.04M | $57.86M | -$232.2M | -$20.59M |
| Common Stock Issued | $19K | $108K | $253K | $503K | $1.25M | $294K |
| **Financing Cash Flow** | $19K | $108K | $253K | $503K | $311.1M | $39.60M |
| **Net Change in Cash** | $4.47M | -$3.60M | $1.77M | -$18.14M | $21.84M | -$28.30M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.42M | -$7.46M | -$7.67M | -$6.63M | -$7.14M | -$8.56M | -$11.04M | -$15.94M |
| Depreciation & Amortization | $66K | $171K | $203K | $255K | $290K | $347K | $399K | $426K |
| Stock-Based Compensation | $506K | $552K | $545K | $1.04M | $407K | $625K | $709K | $1.18M |
| **Operating Cash Flow** | -$3.08M | -$6.54M | -$8.02M | -$7.16M | -$9.73M | -$9.60M | -$13.37M | -$14.43M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$14.43M |
| Purchases of Investments | $0 | $0 | -$1.23M | -$11.84M | -$1.72M | -$14.46M | -$992K | -$13.25M |
| **Investing Cash Flow** | $4.00M | $7.77M | $7.92M | $1.07M | $17.88M | $10.79M | $14.55M | $12.23M |
| Common Stock Issued | $0 | $19K | $6.0K | $5.0K | $0 | $14K | $0 | -- |
| **Financing Cash Flow** | $0 | $19K | $6.0K | $5.0K | $0 | $14K | $0 | $29K |
| **Net Change in Cash** | $922K | $1.25M | -$94K | -$6.08M | $8.15M | $1.21M | $1.19M | -$2.17M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -469.3% | -949.9% | -967.4% | -1576.6% | -7364.1% | -21290.9% |
| **Net Profit Margin** | -433.7% | -820.8% | -878.6% | -1537.8% | -7824.7% | -26289.2% |
| Return on Equity (ROE) | -125.9% | -110.4% | -61.4% | -51.4% | -39.4% | -- |
| Return on Assets (ROA) | -58.8% | -63.4% | -43.3% | -38.7% | -32.0% | -130.5% |
| Current Ratio | 3.59x | 3.20x | 5.17x | 7.47x | 8.87x | 2.25x |
| Quick Ratio | 3.77x | 4.43x | 6.29x | 8.34x | 8.73x | 2.03x |
| Debt to Equity | 0.87x | 0.44x | 0.18x | 0.13x | 0.10x | -- |
| **Revenue Growth (YoY)** | +0.1% | -2.4% | +37.5% | +354.7% | +445.5% | -- |
| 5Y Revenue / Share Growth | +3354.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1098.0% | -654.5% | -492.8% | -469.3% | -884.4% | -1312.3% | -1871.1% | -949.9% |
| **Net Profit Margin** | -1034.4% | -614.9% | -461.7% | -433.7% | -821.6% | -1217.0% | -1741.3% | -820.8% |
| Return on Equity (ROE) | -305.8% | -231.6% | -154.7% | -125.9% | -133.0% | -130.6% | -135.3% | -110.4% |
| Return on Assets (ROA) | -73.6% | -71.9% | -62.5% | -58.8% | -65.6% | -67.2% | -73.8% | -63.4% |
| Current Ratio | 2.05x | 2.61x | 3.32x | 3.59x | 3.57x | 3.11x | 3.13x | 3.20x |
| Quick Ratio | 1.80x | 2.30x | 3.08x | 3.77x | 3.89x | 3.94x | 4.28x | 4.43x |
| Debt to Equity | 2.44x | 1.73x | 1.15x | 0.87x | 0.73x | 0.62x | 0.53x | 0.44x |
| **Revenue Growth (YoY)** | -100.0% | -99.7% | -97.9% | -- | +90.1% | +41.5% | -76.8% | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
